Multi‑omics analysis identifies different molecular subtypes with unique outcomes in early-stage poorly differentiated lung adenocarcinoma

Abstract Introduction Early-stage poorly differentiated lung adenocarcinoma (LUAD) is plagued by a high risk of postoperative recurrence, and its prognostic heterogeneity complicates treatment and surveillance planning. We conducted this integrative multi-omics study to identify those patients with...

詳細記述

書誌詳細

主要な著者:	Bing Liu, Wei Tao, Xuantong Zhou, Li-Di Xu, Yanrui Luo, Xin Yang, Qingjie Min, Miao Huang, Yuge Zhu, Xinrun Cui, Yaqi Wang, Tongyang Gong, Enli Zhang, Yu S. Huang, Weizhi Chen, Shi Yan, Nan Wu
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2025-05-01
シリーズ:	Molecular Cancer
主題:	Multi-omics Poorly differentiated Lung adenocarcinoma
オンライン･アクセス:	https://doi.org/10.1186/s12943-025-02333-7
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!